ClinConnect ClinConnect Logo
Search / Trial NCT06245434

Circadian Rhythmicity During Coma Awakening

Launched by HOSPICES CIVILS DE LYON · Jan 30, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Circadian Rhythms Consciousness Wakefulness Biomarkers Monoamines

ClinConnect Summary

This clinical trial, titled "Circadian Rhythmicity During Coma Awakening," is studying how patients recover from coma after an acute brain injury. Researchers want to understand the natural process of waking up from coma, including how the body's internal clock (circadian rhythms) influences this recovery. By gathering detailed information about patients' awakening patterns, the goal is to find better ways to help those in coma and to identify signs that might indicate when someone is ready for treatment.

To be eligible for the trial, participants must be 17 years or older and have been admitted to a neurological intensive care unit with a significant disorder of consciousness. This includes patients who are on mechanical ventilation and have been sedated for more than 24 hours, or those who show minimal consciousness but can still communicate in some way. Participants can expect to undergo regular assessments to track their recovery progress and may be part of a group that helps researchers learn more about how to improve care for patients in similar situations. It’s important to know that the study aims to enhance understanding and treatment options for patients who have experienced severe brain injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Group 1
  • Admission to the Neurological Intensive Care Unit
  • Initial disorder of consciousness (GCS \< 8) or initial brain lesion (on CT or MRI) requiring intubation and sedation during management (for upper airway protection or due to coma)
  • Duration of sedation by general anesthesia (Propofol, Midazolam) \> 24 h or any use of barbiturate coma or surgery to treat intracranial hypertension
  • Intubated patient under mechanical ventilation with ongoing sedation in sufficient dose (Propofol \> 1 mg/Kg/h and/or Midazolam \< 0.05 mg/Kg/h and/or any dose of Nesdonal)
  • Weaning from sedation possible within 7 days of inclusion in the absence of new complications
  • Severity of clinical or morphological impairment leading to risk of persistent disturbance of consciousness on discontinuation of sedations
  • Sedation discontinuation can be scheduled within 1 month of initial management of the disorder of consciousness or brain injury
  • Effective treatment of the cause of admission without risk of short-term recurrence
  • Patient aged 17 or over
  • Urinary catheter in place at the time of inclusion and to remain in place until Visit N°1
  • Presence of relatives able to sign consent or of the minor's legal representative
  • Group 2
  • Admission to the Neurological Intensive Care Unit or the Neurological Continuing Care Unit
  • * Absence of severe disorder of consciousness but possibility of minimal alteration of the initial Glasgow score (GCS between 9 and 15) with no time limit, with a stratification of three consecutive patient populations distinguished by the initial neurological alteration:
  • GCS = 15
  • GCS \< 15 by predominance of an initial defect in responses to simple or complex commands obtained by motor or verbal means, without abnormality of arousal (E score = 4 but M score \< 6 and/or V score \< 5)
  • GCS \< 15 with predominant initial somnolence, with or without abnormal motor or verbal responses to simple or complex commands (E score = 2 or 3 but M score = 6 and/or V score = 5).
  • Existence of functional communication or functional use of objects at inclusion
  • Mechanism of injury for which the aetiology is no longer active or at risk of recurrence
  • Patient aged 17 or over
  • Urinary catheter in place at the time of inclusion and to remain in place until Visit N°1
  • In the case of impaired judgement despite functional communication or in the case of aphasia with functional use of objects: presence of relatives able to sign consent or of the legal representative of the minor or of the legal representative of the protected adult.
  • Group 3
  • Admission to the Adult Post-Resuscitation Rehabilitation Department
  • * Disturbance of consciousness defined by an absence of communication or an absence of functional use of objects (for patients with aphasia), i.e. the two signs that could indicate emergence from the pauci-relational state, which includes patients presenting :
  • persistent coma
  • a vegetative state (or unresponsive wakefulness syndrome)
  • a pauci-relational state (MCS- or MCS+ if responding to simple commands).
  • Persistent within the following timeframe
  • More than 3 months after the initial management of the disorder of consciousness or brain injury
  • More than 1 month after a post-anoxic coma.
  • Mechanism of injury for which the aetiology is no longer active or at risk of recurrence
  • Patient aged 17 or over
  • Presence of relatives likely to sign the consent or of the legal representative of a minor or of the legal representative of a protected adult
  • Exclusion Criteria:
  • Group 1
  • Subjects with a contraindication to MRI scans
  • Admission for status epilepticus
  • Existence of status epilepticus during the stay and persisting for \> 24h or presenting an electrical remission for less than 48h prior to inclusion
  • Post-anoxic coma with bilateral abolition of N20 PES cortical responses
  • Coma related to a potentially recurrent cause of coma (tumours, infectious diseases with risk of relapse and inflammatory diseases)
  • Moribund patient (life expectancy \< 24h) or in WLST (no assessment possible of the dynamics of ongoing awakening)
  • Haemodynamic or respiratory instability incompatible with a prolonged attempt to stop sedation (except in the case of scheduled surgery outside the visit dates)
  • Patients under guardianship, curatorship or safeguard of justice
  • Patients not affiliated to the French health insurance system
  • Pregnant women or women of childbearing age without proof of the absence of a current pregnancy
  • Group 2
  • Subjects with a contraindication to MRI scans
  • Epileptic seizures on admission or during the stay
  • Single seizure: if no rapid return to consciousness (GCS \< 8 for \> 12 hours)
  • \> 2 distinct epileptic seizures regardless of the duration of loss of consciousness
  • Status epilepticus
  • Post-anoxic coma with bilateral abolition of N20 cortical PES responses.
  • Coma linked to a potentially recurrent cause of coma (tumour, infection with risk of relapse and inflammation).
  • A moribund patient (life expectancy \< 24 hours) or a patient undergoing WLST with a high risk of death before the end of the study (inclusion possible if no therapeutic escalation is decided in a stabilised patient).
  • Haemodynamic or respiratory instability incompatible with prolonged evaluation of the absence of sedation (risk of general anaesthesia for further failure, except in the case of scheduled surgery outside the visit dates).
  • Patients under guardianship, curatorship or safeguard of justice
  • Patients not affiliated to the French health insurance system
  • Pregnant women or women of childbearing age without proof of the absence of a current pregnancy
  • Group 3
  • Subjects with a contraindication to MRI scans
  • * Epileptic seizures during the week preceding inclusion:
  • Single seizure: if no rapid return to usual state of consciousness for \> 12 hours
  • \> 2 separate comitial seizures regardless of duration of loss of consciousness
  • Epileptic malaise
  • Post-anoxic coma with bilateral abolition of N20 cortical responses to SEP
  • Coma related to a potentially recurrent cause of coma (tumour, infection with risk of relapse and inflammation)
  • Moribund patients (life expectancy \< 24 hours) or patients undergoing WSLT with a high risk of death before the end of the study (inclusion possible if no therapeutic escalation is decided in a stabilised patient).
  • Haemodynamic or respiratory instability incompatible with prolonged evaluation of the absence of sedation (risk of general anaesthesia for further failure, except in the case of scheduled surgery outside the visit dates).
  • Patients under guardianship, curatorship or safeguard of justice prior to the event that provoked their state of chronic disturbance of consciousness. Patients under guardianship because of their chronic disorder of consciousness are eligible for the study.
  • Patients not affiliated to the French health insurance system
  • Pregnant women or women of childbearing age without proof of the absence of a current pregnancy

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Bron, Lyon, France

Patients applied

0 patients applied

Trial Officials

GOBERT FLORENT, M.D. Ph.D.

Principal Investigator

Hospices Civils de Lyon

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported